Meet Isogenica at PEGS Europe 2026 in Lisbon
Isogenica will be at PEGS Europe 2026 as a corporate sponsor, joining the protein and antibody engineering community in Lisbon from 16–19 November. Visit us at booth 423 to discuss how our synthetic VHH antibody discovery and engineering platforms can help accelerate timelines, reduce discovery risk and support reliable lead generation for complex therapeutic programmes.
On Tuesday 17 November, Lurdes Rodrigues-Duarte, Director of Research & Development at Isogenica, will present a 15-minute talk in the Antibody-Based Therapies track: “Precision by Design: VHH Affinity, Specificity, and Site-Specific Conjugation for ADCs, AOCs, and LNPs”. The session will explore how conjugation-ready VHH antibody design can support targeted delivery formats, including ADCs, AOCs and LNPs.